BLOG

This offering involved selling 70.4 million units for $2.45 per unit, with each unit including a 36-month warrant (exercise price of $3.20). ACB was able to achieve a 63% adjusted gross profit from Canadian medical sales in the latest quarter. Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares.

An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. I don’t know if Aurora stock is necessarily going to crash in 2022. But given its current, highly unfavorable dynamics combined with the state of the pot industry in North America and abroad, I’d put my money on it continuing to head south rather than wafting higher in price. Shares of Aurora Cannabis rose 3.2% in early trading Tuesday after the company posted lower sales, but a smaller loss in the fourth quarter of 2021 than a year earlier. 2Two of the biggest players in the cannabis sector will be offering a glimpse of how well the industry is performing later this week when they reveal their latest earnings…

MarketBeat has tracked 6 news articles for Aurora Cannabis this week, compared to 2 articles on an average week. Aurora Cannabis has only been the subject of 1 research reports in the past 90 days. One share of ACB stock can currently be purchased for approximately $0.64. One college student can now replace several coding engineers with AI…

Meanwhile, there’s no reason to believe that scores of competitors will either consolidate, or drop out of the over-served Canadian market. Nor are the country’s consumers likely to shift away from the lower-margin recreational products they seem to favor. And a change in U.S. federal law that would allow pot imports, or a sudden explosion in medical marijuana legalization elsewhere abroad, are both pipe dreams for now. Meanwhile, since marijuana is still a Schedule 1 drug at the federal level in America, foreign companies can’t directly import product into this vast and highly tempting market. Outside of North America, available markets for foreign expansion are few and far between, and often consist of rather restrictive medical marijuana-only regimes . Aurora Cannabis is a Canadian vertically integrated cannabis producer and supplier.

Aurora Cannabis Inc. stock rises Monday, outperforms market

Curaleaf is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CIBC reduced their price target on Aurora Cannabis from C$2.25 to C$1.75 in a research report on Monday, February 13th. Piper Sandler lowered their price target on Aurora Cannabis from $2.00 to $1.00 in a research note on Wednesday, December 28th.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023. Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of Aurora Cannabis is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. In the past three months, Aurora Cannabis insiders have not sold or bought any company stock. Represents the company’s profit divided by the outstanding shares of its common stock. That’s why the bottom lines of most Canadian weed players are, more often than not, written in deep red.

Financial Performance

The https://forex-world.net/ has a quick ratio of 3.16, a current ratio of 4.08 and a debt-to-equity ratio of 0.33. Aurora Cannabis has a 12 month low of $0.63 and a 12 month high of $3.72. Over the last three years, the company’s quarterly gross margin actually fell, and its total expenses are still more than 228% when expressed as a proportion of its quarterly revenue. That suggests it won’t become profitable anytime soon, even with the recent cuts. What’s more, its quarterly revenue declined by 5.9% in the same period, and there’s no indication of it trending back toward its highs in 2019. Reading between the lines, that means Aurora might need to win fights for market share with its competitors to keep growing, as it can’t seem to capture or retain revenue by doing its usual.

EV / Sales ,09x EV / Sales ,78x Nbr of Employees Free-Float 87,9% More FinancialsCompanyAurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and… That capital raise appeared to take some shareholders by surprise, as the company exited the quarter with $430 million in cash versus $334 million in debt. I note that subsequent to the quarter, the company repurchased $128 million of those convertible notes. Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations.

Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

According to 14 stock analysts, the average 12-month stock price forecast for ACB stock is $1.38, which predicts an increase of 115.39%. The company sports one of the most efficient operations in Canada, a steadily growing market share in several important product categories, and a fairly strong balance sheet. Organigram’s only real problem is that it has been weighed down by its less efficient peers. Aurora has repositioned itself as a leading medical cannabis company in both Canada and internationally. Moreover, the company sports a fairly sizable international footprint with established operations in highly sought-after markets like Germany.

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Is Aurora Cannabis (ACB) Outperforming Other Medical Stocks This Year?

The cannabis sectors have been in a downtrend for quite a while, but ACB’s crash is something different. The magnitude of this recent crash is quite extreme, even considering its own history of stock price implosions. Aurora Cannabis’s stock reverse split on the morning of Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020.

Announced toAurora canabiss stock the closing of its previously announced bought deal offering of units of the Company … There may be delays, omissions, or inaccuracies in the Information. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Growing revenue has been a challenge; COVID-19 has negatively impacted the top line, and this will likely continue next quarter.

News

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. While legal cannabis has not gone national yet, some cannabis companies hoping to up their brand profile by partnering with national brands. Consolidation is going to be the key theme among Canadian cannabis companies in 2023 and beyond. 52 week high is the highest price of a stock in the past 52 weeks, or one year.

Aurora has quite the ugly quarterly net loss streak going, and has managed to escape a nine-digit shortfall only once in the past five quarters . This is a summary of recent ratings for Aurora Cannabis and Curaleaf, as reported by MarketBeat.com. Announces a new and unprecedented fall lineup of cannabis products. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. As an investor, you want to buy stocks with the highest probability of success.

Industry, Sector and Symbol

That’s less than half the CA$50 million loss it incurred a year earlier. And the company said it found another CA$60 million to CA$80 million in annual costs that it can trim within 18 months. Among the groups of Nasdaq stocks in trouble this year are crypto names and marijuana stocks. When it comes to cryptos, Washington is clearly attacking the sector. Cannabis stocks have been in a major sell-off in the past few months as concerns about the industry remain.

• We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes.
• Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
• According to 14 analysts, the average rating for ACB stock is “Hold.” The 12-month stock price forecast is $1.38, which is an increase of 115.39% from the latest price.
• According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before.
• MarketBeat has tracked 6 news articles for Aurora Cannabis this week, compared to 2 articles on an average week.

On average, they expect the company’s stock price to reach C$2.31 in the next year. This suggests a possible upside of 165.1% from the stock’s current price. View analysts price targets for ACB or view top-rated stocks among Wall Street analysts.

It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. Aurora Cannabis’ stock was trading at C$1.25 on January 1st, 2023. Since then, ACB shares have decreased by 30.4% and is now trading at C$0.87.

A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Due to the U.S. names trading very cheaply with strong fundamentals, I have positioned the Cannabis Growth Portfolio to focus on U.S. names with no exposure to Canadian operators. Perhaps ACB is a buy for those looking for direct momentum exposure, though I caution that long term holding periods have proven nothing short of disastrous for shareholders. In relation to other Canadian operators, ACB has greater exposure to the medical markets.

Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. And while it technically could make you richer if a disruptive event like cannabis legalization happens and its stock shoots up, there are better bets to be found elsewhere. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization.

The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol markets. It produces approximately 150,000 kilograms of cannabis biomass annually. Aurora Cannabis stock has received a consensus rating of hold.

The average rating score is and is based on 1 buy ratings, 2 hold ratings, and 1 sell ratings. The low in the last 52 weeks of Aurora Cannabis stock was 0.63. According to the current price, Aurora Cannabis is 101.52% away from the 52-week low. The high in the last 52 weeks of Aurora Cannabis stock was 3.69.